Study tests best way to deliver HIV and hepatitis c care to drug users
NCT ID NCT03981445
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 31 times
Summary
This study looks at the best way to provide HIV prevention medicine (PrEP) and hepatitis C treatment to people who inject drugs. About 446 participants will either get all their care at one location or be referred to a specialist elsewhere. The goal is to see which approach leads to better medication adherence and higher hepatitis C cure rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAVENOUS DRUG USAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center
New York, New York, 10032, United States
-
Miami
Miami, Florida, 33136, United States
-
Montreal
Montreal, Quebec, Canada
Conditions
Explore the condition pages connected to this study.